אינג'י 10 מג80 מג טבליות

Nchi: Israeli

Lugha: Kiebrania

Chanzo: Ministry of Health

Viambatanisho vya kazi:

EZETIMIBE; SIMVASTATIN

Inapatikana kutoka:

MERCK SHARP & DOHME ISRAEL LTD

ATC kanuni:

C10AA01

Dawa fomu:

טבליה

Tungo:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

Njia ya uendeshaji:

פומי

Dawa ya aina:

מרשם נדרש

Viwandani na:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Kundi la matibabu:

SIMVASTATIN

Eneo la matibabu:

SIMVASTATIN

Matibabu dalili:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Idhini ya tarehe:

2012-04-30